ReShape Lifesciences (RSLS) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free RSLS Stock Alerts $0.17 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:01 AM | finance.yahoo.comQ1 2024 ReShape Lifesciences Inc Earnings CallMay 16 at 10:01 AM | finance.yahoo.comReshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 15 at 4:05 PM | globenewswire.comReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateMay 14 at 8:31 AM | globenewswire.comReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateApril 16, 2024 | morningstar.comReshape Lifesciences Inc RSLSApril 7, 2024 | seekingalpha.comRSLS ReShape Lifesciences Inc.April 3, 2024 | msn.comWill GLP-1 medications replace weight loss surgery?April 3, 2024 | finance.yahoo.comReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagApril 2, 2024 | finance.yahoo.comQ4 2023 ReShape Lifesciences Inc Earnings CallApril 1, 2024 | globenewswire.comReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateMarch 29, 2024 | benzinga.comLatest News for Reshape Lifesciences Stock (NASDAQ:RSLS)March 28, 2024 | finanznachrichten.deReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemMarch 28, 2024 | globenewswire.comReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemMarch 4, 2024 | msn.comReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut planMarch 4, 2024 | globenewswire.comReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXFebruary 29, 2024 | investing.comReShape Lifesciences Inc (RSLS)February 29, 2024 | edition.cnn.comReShape Lifesciences, Inc.February 24, 2024 | thestreet.comReShape Lifesciences Inc.February 22, 2024 | benzinga.comReshape Lifesciences Stock (NASDAQ:RSLS) Insider TradesFebruary 22, 2024 | finance.yahoo.comReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXFebruary 22, 2024 | finance.yahoo.comReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXFebruary 22, 2024 | globenewswire.comReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXJanuary 24, 2024 | finance.yahoo.comReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXDecember 20, 2023 | marketwatch.comReShape Lifesciences Shares Rise 5.6% on Potential Strategic Merger and Acquisition Partnership AlternativesDecember 13, 2023 | msn.comWhy ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketDecember 13, 2023 | msn.comWhy ReShape Lifesciences Stock Is Ripping HigherDecember 13, 2023 | investorplace.comWhy Is ReShape Lifesciences (RSLS) Stock Up 68% Today?December 13, 2023 | finanznachrichten.deReShape Lifesciences Inc: ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEXDecember 13, 2023 | msn.comReShape Lifesciences spikes as FDA clears new weight loss optionDecember 12, 2023 | marketwatch.comReShape Lifesciences Gets FDA Approval for PMA Supplement Used in Latest Lap-BandDecember 12, 2023 | marketwatch.comReShape Lifesciences Shares Surge 31% After Modified Treatment Gets FDA OKNovember 21, 2023 | finance.yahoo.comReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross ProceedsNovember 8, 2023 | finance.yahoo.comReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction PlanNovember 7, 2023 | benzinga.comA Preview Of Reshape Lifesciences's EarningsNovember 6, 2023 | finance.yahoo.comReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate UpdateSeptember 29, 2023 | finance.yahoo.comReShape Lifesciences® Announces Pricing of $3.0 Million Public OfferingSeptember 22, 2023 | finance.yahoo.comReShape Lifesciences® Announces Participation in the LD Micro Main Event XVISeptember 19, 2023 | finance.yahoo.comReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon SystemSeptember 14, 2023 | finanznachrichten.deReShape Lifesciences Inc: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation DeviceSeptember 14, 2023 | finance.yahoo.comReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceSeptember 13, 2023 | uk.finance.yahoo.comRSLS - ReShape Lifesciences Inc.August 9, 2023 | insidermonkey.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call TranscriptAugust 9, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Augmedix (AUGX), ReShape Lifesciences (RSLS)August 8, 2023 | finance.yahoo.comQ2 2023 ReShape Lifesciences Inc Earnings CallAugust 8, 2023 | finance.yahoo.comReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate UpdateAugust 3, 2023 | finance.yahoo.comReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate UpdateJune 29, 2023 | finanznachrichten.deReShape Lifesciences Inc: ReShape Lifesciences Signs Preferred Partner Agreement With Hive Medical for Lead Optimization SoftwareJune 29, 2023 | finance.yahoo.comReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization SoftwareJune 28, 2023 | finance.yahoo.comReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual MeetingJune 27, 2023 | finanznachrichten.deReShape Lifesciences Inc: ReShape Lifesciences Submits FDA PMA Supplement Application for the Next-Generation Lap-Band 2.0 Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent: They're Coming for Your Retirement Money Next! (Ad)According to this data from the US Census Bureau it's possible that by 2040 an average home could cost over $1.2 million, and the average car over $65k. But gold could jump to over $12,000 an ounce if it simply stays on the same path that it's been on for two decades. Don’t delay - secure your future before it’s too late. Click here to claim your free kit now RSLS Media Mentions By Week RSLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.430.54▲Average Medical News Sentiment RSLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼71▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DYNT News INVO News AFIB News QNRX News IONM News BJDX News TNON News NMRD News AEMD News SINT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RSLS) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldGold Set to EXPLODE!Gold Safe ExchangeDoes this make you sick?Allegiance GoldUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalHow Biden has already won 2024Porter & Company348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyUrgent: They're Coming for Your Retirement Money Next!Lear Capital Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
